Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,169 | 146 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $596.82 | 23 | $0 (2023) |
| Amgen Inc. | $548.87 | 23 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $408.86 | 8 | $0 (2019) |
| Novo Nordisk Inc | $247.18 | 19 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $204.14 | 7 | $0 (2019) |
| PFIZER INC. | $171.16 | 13 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $162.48 | 12 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $155.85 | 3 | $0 (2024) |
| Astellas Pharma US Inc | $137.05 | 9 | $0 (2019) |
| Optinose US, Inc. | $124.99 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $75.29 | 4 | Lilly USA, LLC ($42.24) |
| 2023 | $144.15 | 3 | AstraZeneca Pharmaceuticals LP ($112.57) |
| 2022 | $132.32 | 8 | Amgen Inc. ($64.67) |
| 2020 | $65.17 | 4 | Amarin Pharma Inc. ($19.87) |
| 2019 | $599.69 | 36 | AstraZeneca Pharmaceuticals LP ($133.83) |
| 2018 | $844.26 | 40 | Amgen Inc. ($199.79) |
| 2017 | $1,308 | 51 | Boehringer Ingelheim Pharmaceuticals, Inc. ($362.15) |
All Payment Transactions
146 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/29/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: Diabetes | ||||||
| 08/20/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Bone Health | ||||||
| 05/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/08/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Diabetes | ||||||
| 09/25/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: VACCINES | ||||||
| 05/04/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $112.57 | General |
| Category: Respiratory | ||||||
| 03/08/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: Obesity | ||||||
| 09/13/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Obesity | ||||||
| 08/31/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: Bone Health | ||||||
| 08/10/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $12.43 | General |
| Category: Bone Health | ||||||
| 04/26/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Bone Health | ||||||
| 04/14/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: NEUROSCIENCE | ||||||
| 03/29/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Bone Health | ||||||
| 02/16/2022 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Obesity | ||||||
| 03/06/2020 | Mylan Specialty L.P. | Yupelri (Drug), Perforomist | Food and Beverage | In-kind items and services | $11.38 | General |
| Category: Respiratory and Allergy | ||||||
| 03/03/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Cardiovascular | ||||||
| 02/25/2020 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: NEUROSCIENCE | ||||||
| 01/31/2020 | Allergan, Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/17/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/03/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $10.87 | General |
| Category: Central Nervous System (CNS) | ||||||
| 11/26/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, JANUMET XR | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/15/2019 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $11.39 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 11/01/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $12.52 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/22/2019 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 2,146 | 5,347 | $566,819 | $167,137 |
| 2022 | 30 | 3,378 | 7,007 | $628,081 | $205,452 |
| 2021 | 26 | 1,843 | 5,383 | $487,964 | $140,752 |
| 2020 | 24 | 2,036 | 5,234 | $443,421 | $130,501 |
All Medicare Procedures & Services
112 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 25 | 2,640 | $309,333 | $48,222 | 15.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 298 | 534 | $103,044 | $43,742 | 42.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 172 | 172 | $35,432 | $22,021 | 62.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 146 | 173 | $23,492 | $10,478 | 44.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 69 | 71 | $12,113 | $4,884 | 40.3% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 102 | 102 | $6,324 | $4,100 | 64.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 13 | 13 | $7,609 | $3,663 | 48.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 22 | 22 | $6,820 | $3,456 | 50.7% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 24 | 24 | $4,608 | $2,955 | 64.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $8,073 | $2,887 | 35.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 145 | 183 | $6,588 | $2,380 | 36.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 171 | 226 | $5,996 | $2,316 | 38.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 27 | 27 | $5,319 | $2,228 | 41.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 70 | 71 | $3,121 | $2,111 | 67.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 180 | 249 | $3,962 | $2,092 | 52.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 170 | 220 | $4,940 | $1,658 | 33.6% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 58 | 78 | $3,510 | $1,276 | 36.3% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 26 | 26 | $2,552 | $1,005 | 39.4% |
| 82306 | Vitamin d-3 level | Office | 2023 | 32 | 33 | $2,343 | $957.33 | 40.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 48 | 71 | $1,846 | $660.52 | 35.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 21 | 21 | $1,073 | $633.15 | 59.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 29 | 52 | $2,340 | $586.04 | 25.0% |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | Office | 2023 | 11 | 11 | $649.00 | $499.62 | 77.0% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 33 | 52 | $1,248 | $459.68 | 36.8% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 51 | 55 | $1,100 | $435.05 | 39.6% |
About Dr. Sheba Mohsin, M.D
Dr. Sheba Mohsin, M.D is a Family Medicine healthcare provider based in Williamsburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2008. The National Provider Identifier (NPI) number assigned to this provider is 1225290679.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sheba Mohsin, M.D has received a total of $3,169 in payments from pharmaceutical and medical device companies, with $75.29 received in 2024. These payments were reported across 146 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($3,169).
As a Medicare-enrolled provider, Mohsin has provided services to 9,403 Medicare beneficiaries, totaling 22,971 services with total Medicare billing of $643,842. Data is available for 4 years (2020–2023), covering 112 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Williamsburg, VA
- Active Since 06/26/2008
- Last Updated 10/02/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1225290679
Products in Payments
- Prolia (Biological) $303.03
- FARXIGA (Drug) $236.94
- XARELTO (Drug) $204.14
- JARDIANCE (Drug) $167.45
- CHANTIX (Drug) $157.53
- Saxenda (Drug) $136.03
- JANUVIA (Drug) $132.39
- Xhance (Drug) $124.99
- ENTRESTO (Drug) $124.91
- BYDUREON (Drug) $121.91
- TEZSPIRE (Biological) $112.57
- EVENITY (Biological) $81.25
- FASENRA (Drug) $71.82
- MYRBETRIQ (Drug) $65.75
- Aimovig (Biological) $63.67
- Trintellix (Drug) $62.24
- Myrbetriq (Drug) $57.77
- SYMBICORT (Drug) $42.40
- MOUNJARO (Drug) $42.24
- Victoza (Drug) $41.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Williamsburg
Richard Bagnall, Md, MD
Family Medicine — Payments: $8,648
Bruce Mayer, Md, MD
Family Medicine — Payments: $7,474
Mrs. Monique Sessler, Md, MD
Family Medicine — Payments: $5,642
Elena Viterbo-Noble, Md, MD
Family Medicine — Payments: $5,442
Dr. Jamie Rygielski, D.o, D.O
Family Medicine — Payments: $4,267
Christopher Ciccone, M.d, M.D
Family Medicine — Payments: $3,497